Gill Bejerano

Gill Bejerano

Auto-generated profile, based on publicly available information

Gill Bejerano

Department of Computer Science, Stanford University, Stanford, USA

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2010 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
CMCory Y McLean
Cory Y McLean
DBDave Bristor
Dave Bristor
MHMichael Hiller
Michael Hiller
SCShoa L Clarke
Shoa L Clarke
BSBruce T Schaar
Bruce T Schaar
GBGill Bejerano
Gill Bejerano

18 March 2013 in Nature Reviews Genetics
Verified
Journal Article
Closed access
PDF file
LPLen A. Pennacchio
Len A. Pennacchio
WBWendy Bickmore
Wendy Bickmore
ADAnn Dean
Ann Dean
MNMarcelo A. Nobrega
Marcelo A. Nobrega
GBGill Bejerano
Gill Bejerano

9 March 2011 in Nature
Verified
Journal Article
Open access
PDF file
CMCory Y. McLean
Cory Y. McLean
PRPhilip Reno
Philip Reno
APAlex A. Pollen
Alex A. Pollen
ABAbraham I. Bassan
Abraham I. Bassan
TCTerence D. Capellini
Terence D. Capellini
DKDavid Kingsley
David Kingsley
A computational survey of the human genome has identified more than 500 human-specific genomic deletions that remove sequences that are highly conserved between chimpanzees and other animals. These are genomic changes that are likely to have contributed to unique features of human biology. Most of the deleted sequences are located in the non-coding regions of the genome. The human deletions are enriched near genes involved in neural development and steroid hormone signalling, consistent with previous suggestions that regulatory changes near key developmental control genes may have important roles in human evolution. Specific examples of human-specific deletions include one that affects penile anatomy and another relating to brain size. This study searched for putative regulatory mutations specific to the human lineage by looking for sequences that are highly conserved between chimpanzees and other species, but are not present in the human genome. The 500-odd human-specific deletions tend to lie in non-coding DNA stretches and near genes involved in steroid hormone signalling and neural function. This is illustrated with two examples, one of which affects penile anatomy whereas the other affects brain size. Humans differ from other animals in many aspects of anatomy, physiology, and behaviour; however, the genotypic basis of most human-specific traits remains unknown1. Recent whole-genome comparisons have made it possible to identify genes with elevated rates of amino acid change or divergent expression in humans, and non-coding sequences with accelerated base pair changes2,3,4,5. Regulatory alterations may be particularly likely to produce phenotypic effects while preserving viability, and are known to underlie interesting evolutionary differences in other species6,7,8. Here we identify molecular events particularly likely to produce significant regulatory changes in humans: complete deletion of sequences otherwise highly conserved between chimpanzees and other mammals. We confirm 510 such deletions in humans, which fall almost exclusively in non-coding regions and are enriched near genes involved in steroid hormone signalling and neural function. One deletion removes a sensory vibrissae and penile spine enhancer from the human androgen receptor (AR) gene, a molecular change correlated with anatomical loss of androgen-dependent sensory vibrissae and penile spines in the human lineage9,10. Another deletion removes a forebrain subventricular zone enhancer near the tumour suppressor gene growth arrest and DNA-damage-inducible, gamma (GADD45G)11,12, a loss correlated with expansion of specific brain regions in humans. Deletions of tissue-specific enhancers may thus accompany both loss and gain traits in the human lineage, and provide specific examples of the kinds of regulatory alterations6,7,8 and inactivation events13 long proposed to have an important role in human evolutionary divergence.

11 November 2020 in Nature
Verified
Journal Article
Open access
PDF file
ZCZoonomia Consortium
Zoonomia Consortium
EKElinor Karlsson
Elinor Karlsson
ASAitor Serres
Aitor Serres
JAJoel Armstrong
Joel Armstrong
JJJeremy Johnson
Jeremy Johnson
EKElinor Karlsson
Elinor Karlsson
The Zoonomia Project is investigating the genomics of shared and specialized traits in eutherian mammals. Here we provide genome assemblies for 131 species, of which all but 9 are previously uncharacterized, and describe a whole-genome alignment of 240 species of considerable phylogenetic diversity, comprising representatives from more than 80% of mammalian families. We find that regions of reduced genetic diversity are more abundant in species at a high risk of extinction, discern signals of evolutionary selection at high resolution and provide insights from individual reference genomes. By prioritizing phylogenetic diversity and making data available quickly and without restriction, the Zoonomia Project aims to support biological discovery, medical research and the conservation of biodiversity.

8 May 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
CLCraig B. Lowe
Craig B. Lowe
GBGill Bejerano
Gill Bejerano
DHDavid Haussler
David Haussler
At least 5% of the human genome predating the mammalian radiation is thought to have evolved under purifying selection, yet protein-coding and related untranslated exons occupy at most 2% of the genome. Thus, the majority of conserved and, by extension, functional sequence in the human genome seems to be nonexonic. Recent work has highlighted a handful of cases where mobile element insertions have resulted in the introduction of novel conserved nonexonic elements. Here, we present a genome-wide survey of 10,402 constrained nonexonic elements in the human genome that have all been deposited by characterized mobile elements. These repeat instances have been under strong purifying selection since at least the boreoeutherian ancestor (100 Mya). They are most often located in gene deserts and show a strong preference for residing closest to genes involved in development and transcription regulation. In particular, constrained nonexonic elements with clear repetitive origins are located near genes involved in cell adhesion, including all characterized cellular members of the reelin-signaling pathway. Overall, we find that mobile elements have contributed at least 5.5% of all constrained nonexonic elements unique to mammals, suggesting that mobile elements may have played a larger role than previously recognized in shaping and specializing the landscape of gene regulation during mammalian evolution.

30 August 2022 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
Yosuke TanigawaYosuke Tanigawa
Yosuke Tanigawa
EDEthan S. Dyer
Ethan S. Dyer
GBGill Bejerano
Gill Bejerano
We present WhichTF, a computational method to identify functionally important transcription factors (TFs) from chromatin accessibility measurements. To rank TFs, WhichTF applies an ontology-guided functional approach to compute novel enrichment by integrating accessibility measurements, high-confidence pre-computed conservation-aware TF binding sites, and putative gene-regulatory models. Comparison with prior sheer abundance-based methods reveals the unique ability of WhichTF to identify context-specific TFs with functional relevance, including NF-κB family members in lymphocytes and GATA factors in cardiac cells. To distinguish the transcriptional regulatory landscape in closely related samples, we apply differential analysis and demonstrate its utility in lymphocyte, mesoderm developmental, and disease cells. We find suggestive, under-characterized TFs, such as RUNX3 in mesoderm development and GLI1 in systemic lupus erythematosus. We also find TFs known for stress response, suggesting routine experimental caveats that warrant careful consideration. WhichTF yields biological insight into known and novel molecular mechanisms of TF-mediated transcriptional regulation in diverse contexts, including human and mouse cell types, cell fate trajectories, and disease-associated cells.